Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2006-11-09
2010-02-16
Yu, Misook (Department: 1642)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
Reexamination Certificate
active
07662580
ABSTRACT:
Disclosed are methods for diagnosing breast cancer in a cell sample by detecting an increase in the levels of expression of protein markers in the cell sample as compared to the levels of expression of the same protein markers in a normal, nonneoplastic breast cell sample. Also disclosed is a device for diagnosis of cancer in a cell sample.
REFERENCES:
patent: 2003/0044859 (2003-03-01), Henslee et al.
patent: 2007/0134687 (2007-06-01), Georges et al.
patent: 1946118 (2008-07-01), None
patent: 04/151003 (2004-05-01), None
patent: WO-00/52463 (2000-09-01), None
patent: WO-02/103320 (2002-12-01), None
patent: WO-2004/065583 (2004-08-01), None
patent: WO-2005/028676 (2005-03-01), None
patent: WO-2005/083440 (2005-09-01), None
patent: WO-2006/071843 (2006-07-01), None
patent: WO-2007141595 (2007-12-01), None
Chen et al. “Simultaneous detection of multiple mRNA markers CK19, CEA, c-Met, Her2
eu and hMAM with membrance array, an innovative technique with a great potential for breast cancer diagnosis.”Cancer Letters. (Aug. 2006) 240 (2): 279-288.
International Search Report, International Patent Application No. PCT/IB2006/004269, mailed Feb. 12, 2008 (5 pgs).
Stathopoulou et al. “Real-Time Quantification of CK-19 mRNA-Positive Cells in Peripheral Blood of Breast Cancer Patients Using the Lightcycler System”Clinical Cancer Research(Nov. 2003) 9(14):5145-5151.
Backus John et al. “Identification and characterization of optimal gene expression markers for detection of breast cancer metastasis” Journal of Molecular Diagnostics, vol. 7, No. 3, Aug. 2005 (pp. 327-336).
Chatterjee S K et al. “Cancer biomarkers: knowing the present and predicting the future” Future Oncology, Future Medicine Ltd., London, GB. vol. 1, No. 1, Jan. 1, 2005 (pp. 37-50).
Elliott Bruce E. et al, “The membrane cytoskeletal crosslinker ezrin is required for metastasis of breast carcinoma cells” Breast Cancer Research, vol. 7, No. 3, Mar. 21, 2005 (pp. R365-R373).
Gruenewald Kurt et al. “Mammaglobin gene expression: A superior marker of breast cancer cells in peripheral blood in comparison to epidermal-growth-factor receptor and cytokeratin-19” Laboratory Investigation, vol. 80, No. 7, Jul. 2000. Retrieved from http://breast-cancer-research.com/paperreport/bcr-2000-66689 (1 page).
Imyanitov E N et al., “Mechanisms of breast cancer” Drug Discovery Today: Disease Mechanisms, Elsevier, vol. 1, No. 2, Nov. 1, 2004 (pp. 235-245).
Shen D. et al. “Loss of annexin A1 expression in human breast cancer detected by multiple high-throughput analyses” Biochemical and Biophysical Research communictions, Academic Press Inc., Orlando FL. vol. 326, No. 1. Dec. 31, 2004 (pp. 218-227).
Stathopoulou A et al. “Molecular Detection of Cancer Cells in the Peripheral Blood of Patients with Breast Cancer: Comparison of SK-19, CEA and MASPIN as Detection Markers” Anticancer Research, Helenic Anticancer Institute, Athens, vol. 23, No. 2C, Mar. 1, 2003 (pp. 1883-1890).
Supplementary European Search Report, European Patent Application No. 06851248.2, completed Dec. 19, 2008 (13 pages).
Zhang Dao-Hai et al. “Proteomics of breast cancer: Enhanced expression of cytokeratin 19 in human epidermal growth factor receptor type 2 positive breast tumors” Proteomics, vol. 5, No. 7, May 2005 (pp. 1797-1805).
Bonneau Anne-Marie
Boucher Claudia
Georges Elias
Lanthier Julie
Aurelium BioPharma Inc.
Wilmer Cutler Pickering Hale and Dorr LLP
Yu Misook
LandOfFree
Tissue diagnostics for breast cancer does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tissue diagnostics for breast cancer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tissue diagnostics for breast cancer will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4202908